ALXN
Alexion Pharmaceuticals
ALXN
ALXN
Delisted
ALXN was delisted on the 20th of July, 2021.
650 hedge funds and large institutions have $18B invested in Alexion Pharmaceuticals in 2020 Q1 according to their latest regulatory filings, with 84 funds opening new positions, 266 increasing their positions, 230 reducing their positions, and 92 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding in top 10
Funds holding in top 10: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less first-time investments, than exits
New positions opened: | Existing positions closed:
less funds holding
Funds holding: →
18% less capital invested
Capital invested by funds: $22B → $18B (-$3.95B)
24% less call options, than puts
Call options by funds: $279M | Put options by funds: $367M
Holders
650
Holding in Top 10
19
Calls
$279M
Puts
$367M
Top Buyers
| 1 | +$252M | |
| 2 | +$69.6M | |
| 3 | +$66.4M | |
| 4 |
Millennium Management
New York
|
+$57.6M |
| 5 |
TCM
TimesSquare Capital Management
New York
|
+$56.2M |
Top Sellers
| 1 | -$320M | |
| 2 | -$252M | |
| 3 | -$201M | |
| 4 |
JPMorgan Chase & Co
New York
|
-$173M |
| 5 |
Goldman Sachs
New York
|
-$158M |